1. Home
  2. ENTA vs OVBC Comparison

ENTA vs OVBC Comparison

Compare ENTA & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • OVBC
  • Stock Information
  • Founded
  • ENTA 1995
  • OVBC 1872
  • Country
  • ENTA United States
  • OVBC United States
  • Employees
  • ENTA N/A
  • OVBC N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • OVBC Major Banks
  • Sector
  • ENTA Health Care
  • OVBC Finance
  • Exchange
  • ENTA Nasdaq
  • OVBC Nasdaq
  • Market Cap
  • ENTA 164.6M
  • OVBC 149.1M
  • IPO Year
  • ENTA 2013
  • OVBC N/A
  • Fundamental
  • Price
  • ENTA $7.51
  • OVBC $33.00
  • Analyst Decision
  • ENTA Buy
  • OVBC
  • Analyst Count
  • ENTA 5
  • OVBC 0
  • Target Price
  • ENTA $18.40
  • OVBC N/A
  • AVG Volume (30 Days)
  • ENTA 173.3K
  • OVBC 8.5K
  • Earning Date
  • ENTA 08-08-2025
  • OVBC 07-25-2025
  • Dividend Yield
  • ENTA N/A
  • OVBC 2.72%
  • EPS Growth
  • ENTA N/A
  • OVBC 24.74
  • EPS
  • ENTA N/A
  • OVBC 2.94
  • Revenue
  • ENTA $64,462,999.00
  • OVBC $63,493,000.00
  • Revenue This Year
  • ENTA N/A
  • OVBC N/A
  • Revenue Next Year
  • ENTA $2.75
  • OVBC N/A
  • P/E Ratio
  • ENTA N/A
  • OVBC $11.50
  • Revenue Growth
  • ENTA N/A
  • OVBC 13.62
  • 52 Week Low
  • ENTA $4.09
  • OVBC $21.86
  • 52 Week High
  • ENTA $15.92
  • OVBC $40.99
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.19
  • OVBC 44.21
  • Support Level
  • ENTA $7.15
  • OVBC $32.99
  • Resistance Level
  • ENTA $8.31
  • OVBC $34.81
  • Average True Range (ATR)
  • ENTA 0.48
  • OVBC 0.91
  • MACD
  • ENTA 0.01
  • OVBC -0.21
  • Stochastic Oscillator
  • ENTA 55.73
  • OVBC 25.24

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.

Share on Social Networks: